Dallah Healthcare Company (TADAWUL:4004)

Market Cap	12.61B
Revenue (ttm)	3.77B
Net Income (ttm)	535.63M
Shares Out	101.20M
EPS (ttm)	5.39
PE Ratio	23.11
Forward PE	21.13
Dividend	2.00 (1.61%)
Ex-Dividend Date	Nov 11, 2025

Volume	52,191
Average Volume	68,031
Open	124.50
Previous Close	124.60
Day's Range	123.60 - 125.10
52-Week Range	109.00 - 164.00
Beta	0.07
RSI	33.05
Earnings Date	Mar 11, 2026

About Dallah Healthcare Company

Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, medical centres, complexes, and clinics; and the provision of manpower and support services. It manufactures and distributes pharmaceutical, herbal and cosmetic products, and toiletries. In addition, the company manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was for...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1987
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4004

Financial Performance

In 2024, Dallah Healthcare Company's revenue was 3.21 billion, an increase of 8.93% compared to the previous year's 2.94 billion. Earnings were 471.20 million, an increase of 30.84%.